spacer
home > pmps > Winter 2020
PUBLICATIONS

Pharmaceutical Manufacturing and Packing Sourcer

pmps
Winter 2020

   
Text
PDF
bullet
Feature topics
Serious Challenges, Great Opportunities

Teemu Patala at Airport College
 
New staff training methods should be considered to achieve excellence in supply chain logistics.
 
view
download pdf
bullet
Extractables and Leachables
An Exercise in Quality Risk Management

Jason Creasey at Maven E&L

‘Extractables’ and ‘leachables’ are mutually exclusive terms, and have a specific value to quality risk management.
 
view
download pdf
Advancing the Detection of E&L by Pharma Manufacturers

Xiaoteng Gong and Dr Dujuan Lu at SGS and Daniela Cavagnino at Thermo Fisher Scientific

Coupling headspace chromatography with mass spectrometry can help assess and quantify volatile extractables in pharma workflows.
 
view
download pdf
Transdermal Delivery Systems

Dr Wayland Rushing at Eurofins

Many problems arise from the increased popularity of transdermal delivery systems, but new FDA guidance may help offset these.
 
view
download pdf
The Landscape for Single-Use Systems

Jessica Shea at Merck 

Single-use systems hold great potential to reduce costs, start-up times, and improve E&L risk evaluation.
 
view
download pdf
Application of Simulation Studies to E&L Programmes

Michael Creese at Smithers

Simulation studies can help scientists in E&L testing ensure the most sterile products and reduce toxicity.
 
view
download pdf
Practical Considerations

Alan Wood at RSSL

Thorough knowledge and planning are required to ensure the E&L study can accommodate a wide range of formulations.
 
view
download pdf
bullet
Green Supply Chain
The Economy or the Environment?

Jason Hibbs at Jet Environmental

The pharma industry should start acting to address the needs of a future-proof sustainable supply chain.
 
view
download pdf
Sustainable Supply Chains

Greg Wheatley at Peli BioThermal

The packaging industry is steadily improving the balance between effective pharmaceutical protection and minimal environmental impact.
 
view
download pdf
Striving to Ship Environmentally Friendly

Aat van der Meer at Dachser Benelux

Third-party service providers may be the solution to an environmentally friendly future.
 
view
download pdf
Making Use of the Reusable

Florence Lehec at EMBALL’ISO Group

Reusable insulated packaging should take the place of single use approaches to ensure minimal damage to the environment.
 
view
download pdf
bullet
Packaging Innovations
A Rapidly Changing Landscape

Tom McClean at West Pharmaceutical Services, Inc

In an ever-evolving market, all pharma healthcare players must learn to innovate swiftly or face being lost by the wayside.
 
view
download pdf
Pharmapack Foreword

Discover the latest developments and packaging solutions, with an exclusive introduction from Pharmapack.
 
view
download pdf
A New Era for Packaging Technologies

Andrew Smith at Rockwell Automation

Despite the technology becoming ever more advanced, it is best to keep packaging lines simple.
 
view
download pdf
Spotlight: How Can Nasal Drug Delivery Devices Increase Patient Compliance and Safety?

Nemera showcase its Advancia®, the nasal spray designed to help improve patient adherence and health.

 
view
download pdf
Smart Packaging: Increasing Therapeutic Adherence

Chris Waterhouse at iDi Pac

Failure to adhere to medication treatment is often a result of forgetfulness, but smart packaging and technology may be a solution.
 
view
download pdf
Thermoforming: The Ideal Product Packaging Solution?

Alastair Cook at ULMA Packaging UK

Thermoforming processes may be the answer as the pharma industry seeks to mitigate costs and waste.
 
view
download pdf
bullet
Inhalation Technology Supplement
Smart Inhalers: The Value and the Challenge

Iain Simpson at Phillips-Medisize

Improved outcomes to patient adherence is a necessity in a world where asthma cases are rising globally. Perhaps smart inhalers hold the solution.
 
view
download pdf
Counteracting the Effects of an Opioid Overdose

Todd D Pizitz and Donald R Mealing at CounterAct

Have we found the way to ameliorate the opioid epidemic that is currently taking hold in the US?
 
view
download pdf
A New Era for Mesh Nebulisers

Hernan Cuevas Brun at HCmed Innovations

Is a renaissance in mesh nebuliser technology upon us? Old methods are being revitalised in new ways to treat respiratory diseases.
 
view
download pdf
Spotlight: Dose Counters and Indicators – A Real Patient Need

H&T Presspart showcases its fully embedded and connected metered-dose inhaler eMDITM, which aims to improve patient adherence.
 
view
download pdf
A Combination of Problems

Lei Mao at Recipharm Laboratories 

Products combining multiple active pharmaceutical ingredients may lead to more effective treatments for patients; however, they are much more complex to create.
 
view
download pdf
   
spacer


Published quarterly in
February, May,
August, and November

News and Press Releases

Cidara Therapeutics Doses First Patient in Pivotal Phase 3 ReSPECT Trial of Rezafungin for Prevention of Invasive Fungal Disease in Patients Undergoing Allogeneic Blood and Marrow Transplantation

SAN DIEGO, Calif. & CAMBRIDGE, England, May 20, 2020 -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company developing long-acting therapeutics to transform the standard of care for patients facing serious fungal or viral infections, and Mundipharma today announced that the first patient has been dosed in its ReSPECT pivotal Phase 3 clinical trial evaluating the efficacy and safety of the company’s lead antifungal candidate, rezafungin, for the prevention of invasive fungal disease in patients undergoing allogeneic blood and marrow transplantation (BMT). Rezafungin is a novel, once-weekly echinocandin being developed for both the treatment and prevention of severe fungal infections.
More info >>

White Papers

Technology Solutions - Driving efficiencies, quality and operational excellence

Worldwide Clinical Trials Ltd

Clinical trials involve the entry, analysis and reporting of millions of pieces of data; year-on-year, the amount of data required to manage efficacy and safety increases exponentially. Recently, solutions available to support this activity have grown in numbers and complexity. The rise of Tablets and Smart Phones combined with the growth of Cloud or SAS solutions has resulted in the technology landscape required to support complex, global studies becoming more confusing.
More info >>

Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement